SL

Sandiyagu Louisraja

Active Director Director DIN 09301364
DIN 09301364 First appointment Sep 2021 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2021
Shareholding value •••• Premium profile

About Sandiyagu Louisraja

Data last updated:

Sandiyagu Louisraja is a Director at Pharma Cubes Private Limited (since 2021). The company operates in Pharma. Pharma Cubes Private Limited reported revenue of ₹8.8 Lakh (FY 2025).

DIN 09301364
Primary Designation Director
Industry Pharma
First Appointment 01 Sep 2021
Oldest Company Age 5 yrs
Largest company Pharma Cubes Private Limited · ₹8.8 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Pharma Cubes Private Limited U24100TN2021PTC145850
Director01 Sep 20212021₹8.8 Lakh (FY 2025)Active

Board colleagues of Sandiyagu Louisraja

Directorship timeline

Open interactive timeline →
Pharma Cubes Private Limited
Premium access

Shareholding and investment profile for Sandiyagu Louisraja

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sandiyagu Louisraja

Sandiyagu Louisraja currently holds 1 directorship: Pharma Cubes Private Limited (Director, since 01 Sep 2021, revenue ₹8.8 Lakh (FY 2025)).

Sandiyagu Louisraja was first appointed on 01 Sep 2021 as Director at Pharma Cubes Private Limited.

The current boards of Sandiyagu Louisraja's companies include Ramanathan Shunmugavel (Pharma Cubes Private Limited), Subburaman Saravanan (Pharma Cubes Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available